Olympus Co. (OTCMKTS:OCPNY – Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $18.00 and traded as high as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares changing hands.
Olympus Price Performance
The stock has a market capitalization of $23.15 billion, a price-to-earnings ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70. The company’s 50-day simple moving average is $18.00 and its 200-day simple moving average is $18.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.99 and a quick ratio of 1.48.
About Olympus
Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.
In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.
See Also
- Five stocks we like better than Olympus
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
